Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
European Child & Adolescent Psychiatry
Erschienen in: European Child & Adolescent Psychiatry 7/2014

01.07.2014 | Review

Nutrition, immunological mechanisms and dietary immunomodulation in ADHD

verfasst von: Annelies A. J. Verlaet, Daniela Briceno Noriega, Nina Hermans, Huub F. J. Savelkoul

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Attention-deficit hyperactivity disorder (ADHD) etiology is not completely understood, but common comorbid dysfunction of the gastrointestinal and immune system suggests that these systems may be affected by a common genetic background and molecular mechanisms. For example, increased levels of specific cytokines were observed in ADHD. Moreover, ADHD has a high comorbidity with both Th1- and Th2-mediated disorders like ear infections, eczema and asthma. A common pathophysiological mechanism was suggested to underlie both asthma and ADHD, while several genes that are linked to ADHD have immune functions. Furthermore, immunological recognition of food provoking ADHD-like behavior was suggested. An immune imbalance, probably requiring a predisposing genetic background, is therefore suggested to contribute to ADHD etiology, with immune dysregulation being more likely than a single subcellular defect. However, next to allergic mechanisms, also pharmacological mechanisms (especially in case of food additives) might be involved. In addition, though cellular (cytokine-related) rather than antibody-mediated immune mechanisms seem involved, specific immune-inflammatory markers other than antibodies have not been systematically studied in ADHD. Substantial alterations implicated in ADHD apparently occur in the immune system and epigenetic regulation of gene expression. As a result, chronic inflammation and oxidative stress could develop, which can lead to ADHD symptoms, for example by chronic T-cell-mediated neuroinflammation. If immune pathways contribute to ADHD, both its diagnosis and treatment should be reconsidered. Modulation of immune system activity might have potential in ADHD treatment, for example by nutritional approaches providing safe and low-cost ADHD therapy, but further research in these fields is implicated.
Literatur
1.
Bierderman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366:237–248CrossRef
2.
Stevens LJ, Kuczek T, Burgess JR, Hurt E, Arnold LE (2011) Dietary sensitivities and ADHD symptoms: 35 years of research. Clin Pediatr 50:279–293CrossRef
3.
Danckaerts M, Sonuga-Barke EJS, Banaschewski T et al (2010) The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatr 19:83–105CrossRef
4.
Pelham WE, Foster EM, Robb JA (2007) The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 32:711–727PubMedCrossRef
5.
Arns M, van der Heijden KB, Arnold LE, Kenemans JL (2013) Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry 74:585–590PubMedCrossRef
6.
Schachter HM, Pham B, King J, Langford S, Moher D (2011) How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents? A meta-analysis. CMAJ 165:1475–1488
7.
Shibib S, Chalhoub N (2009) Stimulant induced psychosis. Child Adolesc Ment Health 14:20–23CrossRef
8.
Westover AN, Halm EA (2012) Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review. BMC Cardiovasc Disord 12:41–50PubMedCentralPubMedCrossRef
9.
Martinez-Raga J, Knecht C, Szerman N, Martinez MI (2013) Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 27:15–30PubMedCrossRef
10.
Silva RR, Skimming JW, Muniz R (2010) Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder. Clin Pediatr (Phila) 49:840–851
11.
12.
Steer CR (2005) Managing attention deficit/hyperactivity disorder: unmet needs and future directions. Arch Dis Child 90:119–125CrossRef
13.
Charach A, Fernandez R (2013) Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatr Rep 15:371–379CrossRef
14.
Wallis D, Russell HF, Muenke M (2008) Review: genetics of attention deficit/hyperactivity disorder. J Pediatr Psychol 33:1085–1099PubMedCrossRef
15.
Poelmans G, Pauls DL, Buitelaar JK, Franke B (2011) Integrated Genome-Wide Association Study Findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatr 168:365–377PubMedCrossRef
16.
17.
Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323PubMedCrossRef
18.
Weber H, Scholz C-J, Jacob CP et al (2013) SPOCK3, a risk gene for adult ADHD and personality disorders. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]
19.
Albayrak Ö, Pütter C, Volckmar AL, Psychiatric GWAS Consortium: ADHD subgroup et al (2013) Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 162B:295–305PubMedCrossRef
20.
Hinney A, Scherag A, Jarick I, Psychiatric GWAS Consortium: ADHD subgroup et al (2011) Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 156B:888–897PubMedCrossRef
21.
Smoller JW, Ripke S, Lee PH, Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium et al (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–1379CrossRef
22.
Lee SH, Ripke S, Neale BM, Cross-Disorder Group of the Psychiatric Genomics Consortium et al (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:984–994PubMedCrossRef
23.
24.
Millichap JG (2008) Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 121:e358–e365PubMedCrossRef
25.
Feder A, Nestler EJ, Westphal M, Charney DS (2010) Psychobiological mechanisms of resilience to stress. In: Reich JW, Zautra AJ, Hall JS (eds) Handbook of adult resilience. The Guilford Press, New York, pp 35–54
26.
Martino M, Rocchi G, Escelsior A, Fornaro M (2012) Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance. Curr Neuropharmacol 10:97–123PubMedCentralPubMedCrossRef
27.
Xiang L, Marshall GD Jr (2011) Immunomodulatory effect of in vitro stress hormones on Foxp3, Th1/Th2 cytokine and costimulatory molecule mRNA expression in human peripheral blood mononuclear cells. NeuroImmunoModulation 18:1–10PubMedCrossRef
28.
Ma L, Chen YH, Chen H, Liu YY, Wang YX (2011) The function of hypothalamus-pituitary-adrenal axis in children with ADHD. Brain Res 1368:159–162PubMedCrossRef
29.
Scahill L, deGraft-Johnson A (1997) Food allergies, asthma, and attention deficit hyperactivity disorder. JCAPN 10:36–40PubMed
30.
Pelsser LM, Buitelaar JK, Savelkoul HFJ (2009) ADHD as a (non) allergic hypersensitivity disorder: A hypothesis. Pediatr Allergy Immunol 20:107–112PubMedCrossRef
31.
Sinn N (2008) Nutritional and dietary influences on attention deficit hyperactivity disorder. Nutr Rev 66:558–568PubMedCrossRef
32.
Millichap JG, Yee MM (2012) The diet factor in attention-deficit/hyperactivity disorder. Pediatrics 129:330–337PubMedCrossRef
33.
Pelsser LM, Frankena K, Toorman J et al (2011) Effects of a restricted elimination diet on the behavior of children with attention-deficit hyperactivity disorder (INCA study): a randomized controlled trial. Lancet 377:494–503PubMedCrossRef
34.
Schonwald A (2008) ADHD and Food Additives Revisited. AAP Grand Rounds 19:17
35.
Schab DW, Trinh NT (2004) Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. J Dev Behav Pediatr 25:423–434PubMedCrossRef
36.
Bateman B, Warner JO, Hutchinson E et al (2004) The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child 89:506–511PubMedCentralPubMedCrossRef
37.
Nigg JT, Lewis K, Edinger T, Falk M (2012) Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatr 51:86–97CrossRef
38.
National Collaborating Centre for Mental Health commissioned by the National Institute for Health and Clinical Excellence (NICE) (2009) Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. Leicester and London: The British Psychological Society and The Royal College of Psychiatrist
39.
Rowe KS, Rowe KJ (1994) Synthetic food coloring and behavior: a dose response effect in a double-blind, placebo-controlled, repeated-measures study. J Pediatr 125:694–698CrossRef
40.
Gillies D, Sinn JKH, Lad SS, Leach MJ, Ross MJ (2012) Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents (review). Cochrane Database Syst Rev 7:CD007986
41.
Arnold LE, DiSilvestro RA (2005) Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15:619–627PubMedCrossRef
42.
Konofal E, Lecendreux M, Arnulf I, Mouren MC (2004) Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158:1113–1115PubMedCrossRef
43.
Egger J, Graham PJ, Carter CM, Gumley D, Soothill JF (1985) Controlled trial of oligo-antigenic treatment in hyperkinetic syndrome. Lancet 325:540–545CrossRef
44.
45.
Stevens LJ, Kuczek T, Burgess JR, Stochelski MA, Arnold LE, Galland L (2013) Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children. Nutr Rev 71:268–281PubMedCrossRef
46.
Gaitens T, Kaplan BJ, Freigang B (1998) Absence of an association between IgE-mediated atopic responsiveness and ADHD symptomatology. J Child Psychol Psychiatr 39:427–431CrossRef
47.
Egger J, Stolla A, McEwen LM (1992) Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome. Lancet 339:1150–1153PubMedCrossRef
48.
El-Ansary A, Shaker GH, Rizk MZ (2013) Role of gut–brain axis in the aetiology of neurodevelopmental disorders with reference to autism. J Clinic Toxicol S6
49.
Lupp C, Robertson ML, Wickham ME (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:119–129PubMedCrossRef
50.
Stevens LJ, Zentall SS, Deck JL et al (1995) Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 62:761–768PubMed
51.
Schmitt J, Romanos M, Schmitt NM, Meurer M, Kirch W (2009) Atopic eczema and attention-deficit/hyperactive disorder in a population based–based sample of children and adolescents. JAMA 301:724–726PubMedCrossRef
52.
Fasmer OB, Halmoy A, Eagen TM, Oedegaard KJ, Haavik J (2011) Adult attention deficit hyperactivity disorder is associated with asthma. BMC Psychiatr 11:128–134CrossRef
53.
Buske-Kirschbaum A, Schmitt J, Plessowa F, Romanos M, Weidinger S, Roessner V (2013) Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 38:12–23PubMedCrossRef
54.
Marshall P (1989) Attention deficit disorder and allergy: a neurochemical model of the relation between the illnesses. Psychol Bull 106:434–446PubMedCrossRef
55.
Millichap JG (2011) Attention deficit hyperactivity disorder handbook. A physician’s guide to ADHD, 2nd edn. Springer Science + Business Media, New York
56.
Egger J, Stolla A, McEwen LM (1993) Hyposensitisation for food-induced hyperkinetic syndrome. Lancet 341:115CrossRef
57.
58.
59.
Nopoulos P, Berg S, Castellenos FX, Delgado A, Andreasen NC, Rapoport JL (2000) Developmental brain anomalies in children with attention-deficit hyperactivity disorder. J Child Neurol 15:102–108PubMedCrossRef
60.
Russell VA (2011) Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci 9(9):35PubMed
61.
Chen H, Centola M, Altschul SF, Metzger H (1998) Characterization of gene expression in resting and activated mast cells. J Exp Med 188:1657–1668PubMedCentralPubMedCrossRef
62.
Tsai SJ (2006) Signal transducer and activator of transcription 6 (STAT6) and attention-deficit hyperactivity disorder: a speculative hypothesis. Med Hypotheses 67:1341–1343
63.
Ogdie MN, Macphie L, Minassian SL et al (2003) A genome wide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 72:1268–1279PubMedCentralPubMedCrossRef
64.
Aureli A, Sebastiani P, Del Beato T et al (2008) Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation. Int J Immunopathol Pharma 21:985–991
65.
Pineda DA, Palacio LG, Puerta IC et al (2007) Environmental influences that affect attention deficit/hyperactivity disorder—Study of a genetic isolate. Eur Child Adolesc Psychiatr 16:337–346CrossRef
66.
Roza SJ, Steegers EAP, Verburg BO et al (2008) What is spared by fetal brain-sparing? Fetal circulatory redistribution and behavioral problems in the general population. Am J Epidemiol 168:1145–1152PubMedCrossRef
67.
Hüppi PS (2008) Neuroimaging of brain development—discovering the origins of neuropsychiatric disorders? Ped Res 64:325CrossRef
68.
Murphy TK, Kurlan R, Leckman J (2010) The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 20:317–331PubMedCentralPubMedCrossRef
69.
Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695–10702PubMedCentralPubMedCrossRef
70.
71.
Cochrane S, Beyer K, Clausen M et al (2009) Factors influencing the incidence and prevalence of food allergy. Allergy 64:1246–1255PubMedCrossRef
72.
Shyu CS, Lin HK, Lin CH, Fu LS (2012) Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study. J Micro Immunol Infec 45:237–242CrossRef
73.
Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population based sample. J Epidemiol Community Health 4:269–273CrossRef
74.
Schmitt J, Apfelbacher C, Chen CM et al (2010) Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth control study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404–410PubMedCrossRef
75.
Schmitt J, Buske-Kirschbaum A, Roessner V (2010) Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? a systematic review. Allergy 65:1506–1524PubMedCrossRef
76.
Cuffe SP, Moore CG, McKeown R (2009) ADHD and health services utilization in the national health interview survey. J Atten Disord 12:330–340PubMedCrossRef
77.
Cutuli JJ, Herbers JE, Rinaldi M, Masten AS, Orberg CN (2010) Asthma and behavior in homeless 4–7 year olds. Pediatrics 125:145–151PubMedCrossRef
78.
Yuksel H, Sogut A, Yilmaz O (2008) Attention deficit and hyperactivity symptoms in children with asthma. J Asthma 45:545–547PubMedCrossRef
79.
Boris M, Goldblatt A (2004) Pollen exposure as a cause for the deterioration of neurobehavioral function in children with autism and attention deficit hyperactive disorder: nasal pollen challenge. J Nutr Env Med 14:47–54CrossRef
80.
Romanos M, Buske-Kirschbaum A, Fölster-Holst R, Gerlach M, Weidinger S, Schmitt J (2011) Itches and scratches—is there a link between eczema, ADHD, sleep disruption and food hypersensitivity? Allergy 66:1407–1409PubMedCrossRef
81.
Bradstreet JJ, Smith S, Baral M, Rossignol DA (2010) Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 15:15–32PubMed
82.
Dupont C, Barau E, Molkhou P, Raynaud F, Barbet JP, Dehennin L (1989) Food-induced alterations of intestinal permeability in children with cow’s milk-sensitive enteropathy and atopic dermatitis. JPGN 8:459–465PubMed
83.
Chida Y, Hamer M, Steptoe A (2008) A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 70:102–116PubMedCrossRef
84.
Chen M-H, Su T-P, Chen J-S et al (2013) Higher risk of mood disorders among adolescents with ADHD and asthma: A nationwide prospective study. J Affect Disord [Epub ahead of print]
85.
Chang HY, Seo J-H, Kim HY et al (2013) Allergic diseases in preschoolers are associated with psychological and behavioural problems. Allergy Asthma Immunol Res 5:315–321PubMedCentralPubMedCrossRef
86.
87.
Halfon N, Newachek PW (2010) Evolving notions of childhood chronic illness. JAMA 303:665–666PubMedCrossRef
88.
89.
van Beek AA, Knol EF, de Vos P et al (2012) Recent developments in basophil research: do basophils initiate and perpetuate type 2 T-helper cell responses? Int Arch Allergy Immunol 160:7–17PubMedCrossRef
90.
91.
Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159:2994–2999PubMed
92.
Entringer S, Claudia Buss C, Wadhwa PD (2010) Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes 17:507–516PubMedCentralPubMedCrossRef
93.
Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Torres AR (1995) Is decreased blood plasma concentration of the complement c4b protein associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatr 34:1009–1014CrossRef
94.
Rout U, Mungan N, Dhossche D (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatr 21:141–147CrossRef
95.
Ceylan M, Sener S, Bayraktar AC, Kavutcu M (2012) Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatr Clin Neurosci 66:220–226CrossRef
96.
Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF-α or both. J Neuroimmun 169:161–171CrossRef
97.
Yukawa K, Iso H, Tanaka T et al (2005) Down-regulation of dopamine transporter and abnormal behaviour in STAT6-deficient mice. Int J Mol Med 15:819–825PubMed
98.
Peterson BS, Leckman JF, Tucker D et al (2000) Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders. Arch Gen Psychiatr 57:364–372PubMedCrossRef
99.
Sanchez-Carpintero R, Albesa SA, Crespo N, Villoslada P, Narbona J (2009) A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. J Neurol 256:1103–1108PubMedCrossRef
100.
Toto M, Margari F, Simone M, et al (2012) Antibasal Ganglia Antibodies and Antistreptolysin O in Noncomorbid ADHD. J Atten Disord [Epub ahead of print]
101.
Nghiem DX, Kazimi N, Clydesdale G, Ananthaswamy HN, Kripke ML, Ullrich SE (2001) Ultraviolet A radiation suppresses an established immune response: implications for sunscreen design. J Invest Dermatol 117:1193–1199PubMedCrossRef
102.
Milovanovic M, Heine G, Hallatschek W, Opitz B, Radbruch A, Worm M (2010) Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity. J Allergy Clin Immunol 126:1016–1023PubMedCrossRef
Metadaten
Titel
Nutrition, immunological mechanisms and dietary immunomodulation in ADHD
verfasst von
Annelies A. J. Verlaet
Daniela Briceno Noriega
Nina Hermans
Huub F. J. Savelkoul
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 7/2014
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-014-0522-2

Weitere Artikel der Ausgabe 7/2014

European Child & Adolescent Psychiatry 7/2014 Zur Ausgabe

Original Contribution

Deficits in motor abilities and developmental fractionation of imitation performance in high-functioning autism spectrum disorders

Original Contribution

Change in psychological problems of adolescents with and without visual impairment

Original Contribution

Psychiatric disorders in preschoolers: the structure of DSM-IV symptoms and profiles of comorbidity

Original Contribution

Anhedonia and depressed mood in adolescence: course, stability, and reciprocal relation in the TRAILS study

Original Contribution

Outcomes of childhood conduct problem trajectories in early adulthood: findings from the ALSPAC study

Editorial

The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein
weitere anzeigen

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen